Global Cellular Reprogramming Tools Market Research Report 2024

Publication ID:

PB506243073

Publication Date:

June 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Cellular Reprogramming Tools market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cellular Reprogramming Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cellular Reprogramming Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cellular Reprogramming Tools in Drug Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cellular Reprogramming Tools include Celgene, BIOTIME, Human Longevity, Advanced Cell Technology, Mesoblast, STEMCELL Technologies, Osiris Therapeutics, Cynata and Astellas Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cellular Reprogramming Tools, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Reprogramming Tools.
Report Scope
The Cellular Reprogramming Tools market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular Reprogramming Tools market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Reprogramming Tools companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celgene
BIOTIME
Human Longevity
Advanced Cell Technology
Mesoblast
STEMCELL Technologies
Osiris Therapeutics
Cynata
Astellas Pharma
FUJIFILM Holdings
EVOTEC
Japan Tissue Engineering
Segment by Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Other
Segment by Application
Drug Development
Regenerative Medicine
Toxicity Test
Academic Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Reprogramming Tools companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Reprogramming Tools Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adult Stem Cells
1.2.3 Human Embryonic Stem Cells
1.2.4 Induced Pluripotent Stem Cells
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cellular Reprogramming Tools Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Development
1.3.3 Regenerative Medicine
1.3.4 Toxicity Test
1.3.5 Academic Research
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular Reprogramming Tools Market Perspective (2019-2030)
2.2 Cellular Reprogramming Tools Growth Trends by Region
2.2.1 Global Cellular Reprogramming Tools Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cellular Reprogramming Tools Historic Market Size by Region (2019-2024)
2.2.3 Cellular Reprogramming Tools Forecasted Market Size by Region (2025-2030)
2.3 Cellular Reprogramming Tools Market Dynamics
2.3.1 Cellular Reprogramming Tools Industry Trends
2.3.2 Cellular Reprogramming Tools Market Drivers
2.3.3 Cellular Reprogramming Tools Market Challenges
2.3.4 Cellular Reprogramming Tools Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Reprogramming Tools Players by Revenue
3.1.1 Global Top Cellular Reprogramming Tools Players by Revenue (2019-2024)
3.1.2 Global Cellular Reprogramming Tools Revenue Market Share by Players (2019-2024)
3.2 Global Cellular Reprogramming Tools Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Reprogramming Tools Revenue
3.4 Global Cellular Reprogramming Tools Market Concentration Ratio
3.4.1 Global Cellular Reprogramming Tools Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Reprogramming Tools Revenue in 2023
3.5 Cellular Reprogramming Tools Key Players Head office and Area Served
3.6 Key Players Cellular Reprogramming Tools Product Solution and Service
3.7 Date of Enter into Cellular Reprogramming Tools Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Reprogramming Tools Breakdown Data by Type
4.1 Global Cellular Reprogramming Tools Historic Market Size by Type (2019-2024)
4.2 Global Cellular Reprogramming Tools Forecasted Market Size by Type (2025-2030)
5 Cellular Reprogramming Tools Breakdown Data by Application
5.1 Global Cellular Reprogramming Tools Historic Market Size by Application (2019-2024)
5.2 Global Cellular Reprogramming Tools Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cellular Reprogramming Tools Market Size (2019-2030)
6.2 North America Cellular Reprogramming Tools Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cellular Reprogramming Tools Market Size by Country (2019-2024)
6.4 North America Cellular Reprogramming Tools Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular Reprogramming Tools Market Size (2019-2030)
7.2 Europe Cellular Reprogramming Tools Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cellular Reprogramming Tools Market Size by Country (2019-2024)
7.4 Europe Cellular Reprogramming Tools Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Reprogramming Tools Market Size (2019-2030)
8.2 Asia-Pacific Cellular Reprogramming Tools Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cellular Reprogramming Tools Market Size by Region (2019-2024)
8.4 Asia-Pacific Cellular Reprogramming Tools Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular Reprogramming Tools Market Size (2019-2030)
9.2 Latin America Cellular Reprogramming Tools Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cellular Reprogramming Tools Market Size by Country (2019-2024)
9.4 Latin America Cellular Reprogramming Tools Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Reprogramming Tools Market Size (2019-2030)
10.2 Middle East & Africa Cellular Reprogramming Tools Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cellular Reprogramming Tools Market Size by Country (2019-2024)
10.4 Middle East & Africa Cellular Reprogramming Tools Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celgene
11.1.1 Celgene Company Detail
11.1.2 Celgene Business Overview
11.1.3 Celgene Cellular Reprogramming Tools Introduction
11.1.4 Celgene Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.1.5 Celgene Recent Development
11.2 BIOTIME
11.2.1 BIOTIME Company Detail
11.2.2 BIOTIME Business Overview
11.2.3 BIOTIME Cellular Reprogramming Tools Introduction
11.2.4 BIOTIME Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.2.5 BIOTIME Recent Development
11.3 Human Longevity
11.3.1 Human Longevity Company Detail
11.3.2 Human Longevity Business Overview
11.3.3 Human Longevity Cellular Reprogramming Tools Introduction
11.3.4 Human Longevity Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.3.5 Human Longevity Recent Development
11.4 Advanced Cell Technology
11.4.1 Advanced Cell Technology Company Detail
11.4.2 Advanced Cell Technology Business Overview
11.4.3 Advanced Cell Technology Cellular Reprogramming Tools Introduction
11.4.4 Advanced Cell Technology Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.4.5 Advanced Cell Technology Recent Development
11.5 Mesoblast
11.5.1 Mesoblast Company Detail
11.5.2 Mesoblast Business Overview
11.5.3 Mesoblast Cellular Reprogramming Tools Introduction
11.5.4 Mesoblast Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.5.5 Mesoblast Recent Development
11.6 STEMCELL Technologies
11.6.1 STEMCELL Technologies Company Detail
11.6.2 STEMCELL Technologies Business Overview
11.6.3 STEMCELL Technologies Cellular Reprogramming Tools Introduction
11.6.4 STEMCELL Technologies Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.6.5 STEMCELL Technologies Recent Development
11.7 Osiris Therapeutics
11.7.1 Osiris Therapeutics Company Detail
11.7.2 Osiris Therapeutics Business Overview
11.7.3 Osiris Therapeutics Cellular Reprogramming Tools Introduction
11.7.4 Osiris Therapeutics Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.7.5 Osiris Therapeutics Recent Development
11.8 Cynata
11.8.1 Cynata Company Detail
11.8.2 Cynata Business Overview
11.8.3 Cynata Cellular Reprogramming Tools Introduction
11.8.4 Cynata Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.8.5 Cynata Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Detail
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Cellular Reprogramming Tools Introduction
11.9.4 Astellas Pharma Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.9.5 Astellas Pharma Recent Development
11.10 FUJIFILM Holdings
11.10.1 FUJIFILM Holdings Company Detail
11.10.2 FUJIFILM Holdings Business Overview
11.10.3 FUJIFILM Holdings Cellular Reprogramming Tools Introduction
11.10.4 FUJIFILM Holdings Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.10.5 FUJIFILM Holdings Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Detail
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Cellular Reprogramming Tools Introduction
11.11.4 EVOTEC Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.11.5 EVOTEC Recent Development
11.12 Japan Tissue Engineering
11.12.1 Japan Tissue Engineering Company Detail
11.12.2 Japan Tissue Engineering Business Overview
11.12.3 Japan Tissue Engineering Cellular Reprogramming Tools Introduction
11.12.4 Japan Tissue Engineering Revenue in Cellular Reprogramming Tools Business (2019-2024)
11.12.5 Japan Tissue Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Celgene
BIOTIME
Human Longevity
Advanced Cell Technology
Mesoblast
STEMCELL Technologies
Osiris Therapeutics
Cynata
Astellas Pharma
FUJIFILM Holdings
EVOTEC
Japan Tissue Engineering

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂